These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10204194)
1. Dose response studies: how do we make them conclusive? Källén A; Larsson P Stat Med; 1999 Mar; 18(6):629-41. PubMed ID: 10204194 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the therapeutic value of drugs--a responsibility of clinical pharmacology]. Herken H; Abshagen U Internist (Berl); 1986 Jan; 27(1):3-12. PubMed ID: 3514514 [No Abstract] [Full Text] [Related]
3. Conditioning on certain random events associated with statistical variability in PK/PD. Beal SL J Pharmacokinet Pharmacodyn; 2005 Apr; 32(2):213-43. PubMed ID: 16283533 [TBL] [Abstract][Full Text] [Related]
4. The analysis of dose-response curve from bioassays with quantal response: Deterministic or statistical approaches? Mougabure-Cueto G; Sfara V Toxicol Lett; 2016 Apr; 248():46-51. PubMed ID: 26952004 [TBL] [Abstract][Full Text] [Related]
5. Drug delivery for optimised products: from product life-cycle management to first-generation product concepts. Bhatt PP Expert Opin Drug Deliv; 2005 Jan; 2(1):1-2. PubMed ID: 16296731 [No Abstract] [Full Text] [Related]
6. Positron emission tomography for use in microdosing studies. Wagner CC; Müller M; Lappin G; Langer O Curr Opin Drug Discov Devel; 2008 Jan; 11(1):104-10. PubMed ID: 18175273 [TBL] [Abstract][Full Text] [Related]
7. [Treatment supervision and dose adjustment]. Berlin H Lakartidningen; 1973 Feb; 70(7):597-600. PubMed ID: 4684396 [No Abstract] [Full Text] [Related]
8. [How to determine the optimal dosage of a drug]. Juillet Y; Abadie E Rev Med Interne; 1986 Nov; Spec No():21-7. PubMed ID: 3544114 [TBL] [Abstract][Full Text] [Related]
9. Toxicology evaluation and single intravenous dose studies in human subjects. Colburn WA J Clin Pharmacol; 1997 Jan; 37(1):4-6. PubMed ID: 9048266 [No Abstract] [Full Text] [Related]
10. The future of analytical pharmacology--a personal view. Cridland JS S Afr Med J; 1984 Feb; 65(5):172-3. PubMed ID: 6695274 [TBL] [Abstract][Full Text] [Related]
11. The pharmacology of neurogenesis: Conceptual advances and remaining challenges. Boccazzi M; Ceruti S Biochem Pharmacol; 2017 Oct; 141():1-3. PubMed ID: 28800958 [No Abstract] [Full Text] [Related]
12. Geriatric drug evaluation: where are we now and where should we be in the future? Cho S; Lau SW; Tandon V; Kumi K; Pfuma E; Abernethy DR Arch Intern Med; 2011 May; 171(10):937-40. PubMed ID: 21606098 [TBL] [Abstract][Full Text] [Related]
13. Drugs with aging. Misperceptions about medications. Mayo Clin Health Lett; 2014 Dec; 32(12):7. PubMed ID: 26087529 [No Abstract] [Full Text] [Related]
16. New drugs and drug delivery systems in the year 2000. Check WA Am Pharm; 1984 Sep; NS24(9):44-56. PubMed ID: 6496308 [No Abstract] [Full Text] [Related]
17. Selecting the best dose when a monotonic dose-response relation exists. Russek-Cohen E; Simon RM Stat Med; 1994 Jan; 13(1):87-95. PubMed ID: 9061843 [TBL] [Abstract][Full Text] [Related]
18. The thorny path of clinical pharmacology. Gross F Clin Pharmacol Ther; 1978 Oct; 24(4):383-94. PubMed ID: 688729 [No Abstract] [Full Text] [Related]
19. Hormetic effects in pharmacology: pharmacological inversions as prototypes for hormesis. Furst A Health Phys; 1987 May; 52(5):527-30. PubMed ID: 3570795 [TBL] [Abstract][Full Text] [Related]
20. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process. Bertino JS; Greenberg HE; Reed MD; J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550 [No Abstract] [Full Text] [Related] [Next] [New Search]